High-throughput screening of microbial extracts using rat hepatic microsomal glucose-6-phosphatase (G6Pase) led us to find thielavin B as a G6Pase inhibitor with inhibition of glucose output from glucagon-stimulated hepatocytes. Further searching for more potent analogs identified 11 new thielavins F-P in addition to the known thielavins A and B from a fungus Chaetomium carinthiacum ATCC 46463. Thielavin G showed the strongest activity as a G6Pase Diabetes mellitus is a major chronic disease and a cause of many debilitating and life-threatening complications. Because of such complications and its requirement of long term medical care, patient's "quality of life" has been disturbed. The medical costs associated with the treatment of diabetes mellitus are very large and continue to increase as the population ages and diabetes become more prevalent.
Insulin has been very effective in the treatment of Type 1 diabetes mellitus and is used to treat Type 2 diabetic patients who fail to respond to existing oral therapies. However, there remains a need for additional, more effective oral anti-diabetic agents.
In the course of drug discovery efforts to identify antidiabetic agents, we have focused on glucose-6-phosphatase (G6Pase). G6Pase has been recognized as a key enzyme in glucose homeostasis where G6Pase hydrolyzes glucose-6-phosphate (G6P) to glucose and releases it into the bloodstream. Inhibition of G6Pase activity should decrease hepatic glucose output from both glyconeogenesis and glycogenolysis, which would lead to the lowering of the concentration of plasma glucose in diabetes mellitus1,2).
High throughput screening of our microbial extracts using the rat hepatic microsomal G6Pase enzyme was performed, which led us to identify thielavin B3) as a G6Pase inhibitor with moderate inhibition of glucose output from glucagon (GGN)-stimulated hepatocytes. In the further searching for thielavin-analogs with more potent G6Pase inhibition, including the optimization of in addition to the known thielavins A and B3,4) from the fermentation broth of a fungus Chaetomium carinthiacum ATCC 46463 (Fig. 1) . In this paper we describe producing organisms, fermentation, isolation, structure elucidation and biological activity of a series of thielavins including 11 new analogs. Three hydrolysis products 556, 558) , each of which has 2 benzoic acid-units, were also prepared from thielavins A and B. Their G6Pase-inhibitory activities were also measured and compared with those of the other thielavins including previously isolated authentic thielavins C and D4,5)
Results

Producing Strain and Fermentation
The producing strain, the fungus Chaetomium carinthiacum ATCC 46463 was obtained from the American Type Culture Collection.
ATCC 46463 was maintained on agar slants of potato dextrose agar medium. The cell suspension from the agar slant was used to inoculate 500ml-Erlenmeyer's flasks containing 100ml of seed medium (potato dextrose broth 2.4%, yeast extract 0.5% and agar 0.1%). After incubation aliquots were inoculated into twenty 500ml-Erlenmeyer's flasks containing 50ml of production medium (glucose 1%, glycerol 6.6%, oil-less soybean meal 0.5%, NZ-amine(R) Type A [Wako] 0.5%, (NH4)2SO4 0.2%, tomato paste 0.5% and sodium citrate 0.2%, pH 6.5) and 25g of buckwheat (Nikkoku Seihun). Stationary incubation was carried out at
Isolation of Thielavins
The fermented broth of ATCC 46463 (1.8 liters from 18 flasks) was extracted with 1.8 liters of ethanol for 2 days, and then filtered. The filtered broth (1.5 liters) was concentrated to dryness to yield 22.8g of ethanol extract.
The ethanol extract was suspended into n-butanol-saturated water (300ml) and extracted with water-saturated nextract (5.0g) was then suspended into the lower layer (300 
Structural Elucidation
Thielavins A and B were identified by the direct comparisons with authentic thielavins A-D in our laboratory. The structures of the authentic thielavins had been elucidated by spectrometric analysis including 2D-NMR and by comparisons with previously reported data3-5).
The structural elucidation procedures of the new thielavin analogs 1-11 are essentially the same. Here, the structure elucidation of 2, which is the most potent G6Pase suggests that the remaining 3 protons from the molecular formula are hydroxy groups. The degree of unsaturation from the molecular formula was fifteen: nine were assigned 156.0, 153.9, 151.1, 149.1, 140.8, 137.4, 132.4, 130.9, 126.1, 122.6, 122.3, 122.2, 112.2, 110.2, 104.8 and 103.6 ), remainder to the three rings. In addition to the data comparisons to those of known thielavins, the structure of 2 was elucidated based on the results of HMBC experiment ( Fig. 3 ) and the fragment analysis of the LRFAB-MS ( A, B and C cannot make the fragment ions described above. As the connection of the three benzoyl groups was established, the position of the three hydroxy groups were settled to the remaining three open bonds. Thus, the structure of 2 was determined to be 4-[4'-(2",4"-dihydroxy-3", 6"-dimethylbenzoyloxy)-5',6'-dimethyl-2'-methoxybenzoyloxy]-2-methoxy-3,5,6-trimethylbenzoic acid as shown in Fig. 1 .
Structures of thielavin I (4) and thielavin L (7) were also determined by the same procedure described above. During the analysis, it became clear that 4 has a hydrogen at C-1 and 7 has a carboxylic glyceride at C-1 by HMBC spectra and their molecular formula.
Biological Properties
G6Pase-inhibitory activity of all new thielavins isolated, known thielavins A-D and three partial hydrolysates (12-44, see Fig. 5 and Experimental section) of thielavins A and B were examined (G6Pase Inh. in Table 3 Table 3 ) except for 9. Thielavins 6, 7, 10 and 11 had lower activities thielavin L (7, glycerol ester) and three partial hydrolysates (12-14) showed almost no activity for G6Pase inhibition. -20,556 (12) , 557 (13) and 558 (14) . for 13C-NMR. The peak shapes are denoted as follows: s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), br (broad) and sh (shoulder). All FAB-MS spectra were measured using glycerol as a matrix.
Analytical HPLC of Thielavin Analogs
For the retention times in Table 1, Liner gradient system with acetonitrile (for the Rt/MeCN in Table 1 ): start with 5%-A/C, go up to 30% at 3.0 minutes, increase to 70% at 23.0 minutes, to 100% at 26.0 minutes and stay with 100%-A till 28.5 minutes. On this acetonitrile-condition, known thielavins A, B, C, D and partial hydrolysates (12-14) showed their Rt (minutes) at 19.0, 16.9, 18.9, 15.2, 9.8, 11.5 and 13.5, respectively. Liner gradient system with methanol (for Rt/MeOH in Table 1 ): start with 5%-B/C, immediately go up to 55% at 0.5 minutes, keep increasing to 85% at 25.0 minutes, to 100% at 26.0 minutes and stay 100%-B till 28.5 minutes. 557 (13, 2.7mg), 558 (14, 4.1mg ) and non-reacted thielavin A (7.3mg) were obtained after HPLC separation: same condition as Preparative HPLC described above with flow rate=10 ml/minute, linear gradient system=5%-A/C for first 10 minutes, then increase to 70% at 140 minutes, and to 100% at 150 minutes; Rt=118,128 and 149 minutes, respectively. CJ-20,557 (13): Colorless glass; HRFAB-MS (br), 3126 (br), 2932, 1653, 1622, 1501, 1440 (sh), 1416, 1385, 1308, 1267, 1204, 1150, 1098, 1074, 1030, 841, 800, 725, 708, 623, 600, 583 and 471cm- 
